About 50 results
Open links in new tab
  1. Home│ KCENTRA®

    Administer vitamin K concurrently to patients receiving KCENTRA. Vitamin K is administered to maintain vitamin K–dependent clotting factor levels once the effects of KCENTRA have …

  2. KCENTRA Support│ FAQs

    How does KCENTRA work for urgent warfarin reversal? What distinguishes KCENTRA from plasma/coagulation products for urgent warfarin reversal? Can KCENTRA be prepared and …

  3. How to administer and store│ Reconstitution & Administration

    Storing KCENTRA after reconstitution KCENTRA must be used within 4 hours following reconstitution. Reconstituted product can be stored at 2–25°C. If cooled, the solution should …

  4. Warfarin reversal within minutes│ What is KCENTRA?

    Industry guidelines recommend KCENTRA for urgent warfarin reversal over plasma—explore key clinical uses

  5. Only replace what is needed│ How KCENTRA Works

    Get useful tools and information about how to reconstitute, administer, and store KCENTRA. view reconstitution & administration

  6. Calculate your dose│Dosage Calculator - Kcentra

    KCENTRA dose is calculated using Factor IX content KCENTRA is available in 2 vial sizes for added convenience 500 units for use with 20-mL vial of Sterile Water for Injection, USP 1000 …

  7. Why KCENTRA│ Efficacy

    KCENTRA is the only 4F-PCC approved for both acute major bleeding and urgent surgery

  8. Protocols │Kcentra Orphan Page

    Having KCENTRA on your protocol can improve patient outcomes and shorten hospital stays Overall length of hospital stay was 43% shorter for patients treated with KCENTRA than …

  9. Reimbursement and coding support - Kcentra

    Hospital outpatient and freestanding settings of care Effective July 1, 2021, the Centers for Medicare and Medicaid Services (CMS) has established a permanent, product-specific …

  10. Why KCENTRA│Safety

    Both fatal and nonfatal arterial and venous thromboembolic complications have been reported in clinical trials and postmarketing surveillance. Monitor patients receiving KCENTRA, and inform …